Q1: 2026-05-06 Earnings Summary

EPS of -$0.85 misses by $1.33

|

Revenue of

-$29.00K

(-100.96% Y/Y)

misses by $109.31M

Vir Biotechnology, Inc. ( VIR ) Bank of America Global Healthcare Conference 2026 May 12, 2026 7:20 PM EDT

Company Participants

Marianne De Backer - President, CEO & Director

Conference Call Participants

Alec Stranahan - BofA Securities, Research Division

Presentation

Alec Stranahan

BofA Securities, Research Division

Thanks for joining the session with Vir Biotechnology. My name is Alec Stranahan. I cover SMID-cap biotech at Bank of America, and I'm the covering analyst for Vir. And it's my pleasure to introduce Marianne De Backer, Chief Executive Officer of Vir. Marianne, thanks for being here.

Marianne De Backer

President, CEO & Director

Yes, my pleasure. Thank you.

Question-and-Answer Session

Alec Stranahan

BofA Securities, Research Division

Looking forward to the discussion. I guess just jumping right into it, you've effectively built a 2-engine value story for Vir.…